News
PRGO
25.64
-0.08%
-0.02
Weekly Report: what happened at PRGO last week (1216-1220)?
Weekly Report · 3d ago
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Benzinga · 3d ago
Noteworthy Thursday Option Activity: TEAM, PRGO, CCL
NASDAQ · 6d ago
Weekly Report: what happened at PRGO last week (1209-1213)?
Weekly Report · 12/16 09:16
Dividend Champion, Contender, And Challenger Highlights: Week Of December 15
Seeking Alpha · 12/14 02:40
Independent Director Jeffrey Kindler Sold A Bunch Of Shares In Perrigo
Simply Wall St · 12/12 10:06
Perrigo (PRGO) Passes Through 4% Yield Mark
NASDAQ · 12/10 20:12
Insider Sale: Director at $PRGO (PRGO) Sells 17,598 Shares
Barchart · 12/10 20:02
Weekly Report: what happened at PRGO last week (1202-1206)?
Weekly Report · 12/09 09:15
Is Perrigo (NYSE:PRGO) A Risky Investment?
Simply Wall St · 12/06 10:20
Weekly Report: what happened at PRGO last week (1125-1129)?
Weekly Report · 12/02 09:15
Wolfe’s short ideas: Companies with potential dividend cuts
Seeking Alpha · 11/27 18:45
Ex-Dividend Reminder: Perrigo, Baxter International and National Bank Holdings
NASDAQ · 11/27 16:02
3 Dividend Stocks to Buy Now With Yields of About 4% or More
Barchart · 11/25 18:30
Weekly Report: what happened at PRGO last week (1118-1122)?
Weekly Report · 11/25 09:14
Notable Friday Option Activity: ZM, PRGO, DDOG
NASDAQ · 11/22 20:22
Perrigo Company: Great Combination Of Future Growth With A Low Valuation
Seeking Alpha · 11/19 12:17
Weekly Report: what happened at PRGO last week (1111-1115)?
Weekly Report · 11/18 09:14
March 2025 Options Now Available For Perrigo (PRGO)
NASDAQ · 11/15 17:17
Weekly Report: what happened at PRGO last week (1104-1108)?
Weekly Report · 11/11 09:15
More
Webull provides a variety of real-time PRGO stock news. You can receive the latest news about Perrigo Co Plc through multiple platforms. This information may help you make smarter investment decisions.
About PRGO
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.